Spots Global Cancer Trial Database for anogenital warts
Every month we try and update this database with for anogenital warts cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) | NCT00090285 | Condylomata Acu... | (Gardasil™) hum... Comparator: pla... | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts | NCT05156541 | Human Papilloma... Anogenital Wart... | Interferon gamm... | 18 Years - 50 Years | SPP Pharmaclon Ltd. | |
| Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts | NCT02377999 | Anogenital Wart... | Picato | 18 Years - | LEO Pharma | |
| Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers | NCT01490008 | Anogenital Wart... | Veregen Green Tea | 18 Years - | MediGene | |
| Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) | NCT00365443 | Cervical Cancer Condylomata Acu... | V502 | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers | NCT01490008 | Anogenital Wart... | Veregen Green Tea | 18 Years - | MediGene | |
| Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) | NCT00365443 | Cervical Cancer Condylomata Acu... | V502 | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients | NCT02724254 | Condyloma | AP611074 5% gel AP611074 matchi... | 18 Years - 55 Years | Vaxart | |
| Glizigen-Viudid-External Anogenital Warts in Children and Adolescents | NCT01111344 | External Anogen... | Glizigen + Vius... Placebo | 10 Years - 18 Years | Catalysis SL | |
| Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) | NCT00365443 | Cervical Cancer Condylomata Acu... | V502 | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts | NCT02015260 | Anogenital Wart... Condylomata Acu... | Topical NO Placebo | 18 Years - | University of Aberdeen | |
| Evaluation of Long Term Immunity Following HPV Vaccination | NCT02276521 | Cervical Cancer Anogenital Wart... | Cervarix® | 15 Years - 17 Years | Murdoch Childrens Research Institute | |
| Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts | NCT02377999 | Anogenital Wart... | Picato | 18 Years - | LEO Pharma | |
| Glizigen-Viudid-External Anogenital Warts in Children and Adolescents | NCT01111344 | External Anogen... | Glizigen + Vius... Placebo | 10 Years - 18 Years | Catalysis SL |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
